Rountable Conference
Howard R. Soule, Ph.D.
Executive Vice President
Chief Science Officer
1250 Fourth Street, Suite 360
Santa Monica, CA 90401
Phone: (800) 757-2873
play Modem || Broadband Real Media
Howard R. Soule, Ph.D.

Howard R. Soule, Ph.D. is currently Executive Vice President and Chief Science Officer at CaP CURE, The Association for Cure of Cancer of the Prostate. Dr. Soule is responsible for the coordination of science and clinical research for worldwide prostate cancer programs funded by CaP CURE. This organization has granted over 800 awards totaling more than $100 million since inception in 1993 by prostate cancer survivor and activist Michael Milken.

Dr. Soule is an experienced biotechnology R&D executive having been a corporate officer at Corvas International, a leading cardiovascular drug discovery and development firm. He has also held senior management positions in the medical device industry. Following receipt of his Ph.D. degree from Baylor College of Medicine, Dr. Soule was a postdoctoral fellow at The Scripps Research Institute.

Dr. Soule is a Director for Miavita, a premier health and wellness company and Can Fite Biopharma, an Israel-based biotechnology firm developing anticancer drugs. He is a member of the Scientific Advisory Board of Corvas International, Activx Biosciences, D-Novo and ProQuest Investments. Dr. Soule is a member of the Visiting Committee for the Lank Genitourinary Oncology Program at the Dana-Farber Cancer Institute and the Department of Defense Prostate Cancer Research Integration